Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Pyrrole derivatives for viral conditions synthesized by RPR (Aventis)

Jan. 25, 2000

Major European launch announced for Synagis

Jan. 20, 2000

Therapeutically useful substituted oxazolidinones emerge from R&D at AstraZeneca

Jan. 19, 2000

Hollis-Eden product shows efficacy in chloroquine-resistant malaria

Jan. 19, 2000

FDA issues public health advisory for influenza drugs

Jan. 18, 2000

Oxazolidinones in development at AstraZeneca useful against resistant Gram-positive pathogens

Jan. 18, 2000

Modifications of carbapenem nucleus an important area of research at Merck

Jan. 18, 2000

New Merck carbapenems with activity against methicillin-resistant staphylococci

Jan. 17, 2000

Antex creates new antibiotics to combat antibiotic-resistant bacteria

Jan. 14, 2000

Carbapenems synthesized at Merck active against resistant Gram-positive bacteria

Jan. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...